Advertisement

Infections After Surgery for MBD

  • Giulio Di Giacomo
  • Fabrizio Donati
  • Carlo Perisano
  • Michele Attilio Rosa
  • Giulio Maccauro
Chapter

Abstract

The life expectancy of patients with bone metastases has remarkably increased over recent years leading to higher incidence of bone metastases with major risk of pathological fractures and orthopedic treatments. Orthopedic surgery in bone metastases has a highly diversified approach and could be very invasive, requiring prosthetic implants, allograft, nails, plates or other metallic devices, vascular procedures, and plastic surgery.

Metal wear and especially megaprosthesis implantation are commonly complicated by deep infections, which are probably the most common and severe complication in orthopedic oncological surgery, considered as challenging as local relapse. The rate of infection in these treatments range from 8% to over 40%, with great variability depending on the site of replacement, age, comorbidity, resection size, and histological characteristics of primary malignant tumor involved.

Infection prevention is therefore of the utmost importance considering that, when there are poor soft tissue conditions, secondary amputation is sometimes inevitable.

Postoperative infection complications have also a heavy impact on the cost and management aspects due to hospital readmissions, extended hospitalization, the need for additional procedures, and convalescent or nursing home care.

Great interest is actually spreading about orthopedic infections in bone metastatic disease, as reflected by a great number of literature reviews, monothematic meetings, and multicenter prospective studies. According to this consideration, in this chapter we analyze all the possible actions described to prevent and treat surgical site infections following this kind of surgery, including an appropriate antibiotic prophylaxis, surgical procedures for primary and revision surgery and recent technical improvements.

Keywords

Infection Limb salvage surgery Tumor prosthesis Antibiotic prophylaxis 

References

  1. 1.
    Jeys LM, Grimer RJ, Carter SR, Tillman RM. Periprosthetic infection in patients treated for an orthopaedic oncological condition. J Bone Joint Surg Am. 2005;87:842–9.CrossRefPubMedGoogle Scholar
  2. 2.
    Capanna R, Morris HG, Campanacci D, Del Ben M, Campanacci M. Modular uncemented prosthetic reconstruction after resection of tumours of the distal femur. J Bone Joint Surg Br. 1994;76:178–86.CrossRefPubMedGoogle Scholar
  3. 3.
    Hasan K, Racano A, Deheshi B, Farrokhyar F, Wunder J, et al. Prophylactic antibiotic regimens in tumor surgery (PARITY) survey. BMC Musculoskelet Disord. 2012;13:91.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Matthews PC, Berendt AR, McNally MA, et al. Diagnosis and management of prosthetic joint infection. BMJ. 2009;338:1378–83.CrossRefGoogle Scholar
  5. 5.
    Boxma H, Broekhuizen T, Patka P, et al. Randomised controlled trial of single-dose antibiotic prophylaxis in surgical treatment of closed fractures: the Dutch trauma trial. Lancet. 1996;347:1133–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Schwartz A, Rebecca A, Smith A, Casey W, Ashman J, et al. Risk factors for significant wound complications following wide resection of extremity soft tissue sarcomas. Clin Orthop Relat Res. 2013;471:3612–7.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Whitehouse JD, Friedman ND, Kirkland KB, et al. The impact of surgical-site infections following orthopedic surgery at a community hospital and university hospital: adverse quality of life, excess length of stay and extra cost. Infect Control Hosp Epidemiol. 2002;23:183–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Morii T, Morioka H, Ueda T, Araki N, Hashimoto N, et al. Deep infection in tumor endoprosthesis around the knee: a multi-institutional study by the Japanese musculoskeletal oncology group. BMC Musculoskelet Disord. 2013;14:51.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Racano A, Pazionis T, Farrokhyar F, Deheshi B, Ghert M. High infection rate outcomes in long-bone tumor surgery with endoprosthetic reconstruction in adults: a systematic review. Clin Orthop Relat Res. 2013;471:2017–27.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Shehadeh A, Noveau J, Malawer M, Henshaw R. Late complications and survival of endoprosthetic reconstruction after resection of bone tumors. Clin Orthop Relat Res. 2010;468:2885–95.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Mavrogenis AF, Pala E, Angelini A, Calabro T, Romagnoli C, et al. Infected prostheses after lower-extremity bone tumor resection: clinical outcomes of 100 patients. Surg Infect. 2015;16:267–75.CrossRefGoogle Scholar
  12. 12.
    Trampuz A, Zimmerli W. Antimicrobial agents in orthopedic surgery: prophylaxis and treatment. Drugs. 2006;66:1089–105.CrossRefPubMedGoogle Scholar
  13. 13.
    Meehan J, Jamali AA, Nguyen H. Prophylactic antibiotics in hip and knee arthroplasty. J Bone Joint Surg Am. 2009;91:2480–90.CrossRefPubMedGoogle Scholar
  14. 14.
    Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318–22.CrossRefGoogle Scholar
  15. 15.
    Costerton JW. Biofilm theory can guide the treatment of device-related orthopaedic infections. Clin Orthop Relat Res. 2005;437:7–11.CrossRefGoogle Scholar
  16. 16.
    Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother. 2001;45:999–1007.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Hardes J, Gebert C, Schwappach A, et al. Characteristics and outcome of infections associated with tumor endoprostheses. Arch Orthop Trauma Surg. 2006;126:289–96.CrossRefPubMedGoogle Scholar
  18. 18.
    Antimicrobial prophylaxis for surgery. Treat Guidel Med Lett. 2009;7:47–52.Google Scholar
  19. 19.
    Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection. Infect Control Hosp Epidemiol. 1999;20:250–78.CrossRefGoogle Scholar
  20. 20.
    Jaeger M, Maier D, Kern WV, et al. Antibiotics in trauma and orthopedic surgery—a primer of evidence-based recommendations. Injury. 2006;37:s74–80.CrossRefPubMedGoogle Scholar
  21. 21.
    Bratzler DW, Houck PM, Richards C, et al. Use of antimicrobial prophylaxis for major surgery: baseline results from the National Surgical Infection Prevention Project. Arch Surg. 2005;140:174–82.CrossRefPubMedGoogle Scholar
  22. 22.
    Tobin EJ, Bambauer R. Silver coating of dialysis catheters to reduce bacterial colonization and infection. Ther Apher Dial. 2003;7:504–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Schierholz JM, Lucas LJ, Rump A, Pulverer G. Efficacy of silver-coated medical devices. J Hosp Infect. 1998;40(4):257–62.  https://doi.org/10.1016/s0195-6701(98)90301-2.CrossRefPubMedGoogle Scholar
  24. 24.
    Kim TN, Feng QL, Kim JO, et al. Antimicrobial effects of metal ions (Ag+, Cu2+, Zn2+) in hydroxyapatite. J Mater Sci Mater Med. 1998;9(3):129–34.CrossRefPubMedGoogle Scholar
  25. 25.
    Tweden KS, Cameron JD, Razzouk AJ, Holmberg WR, Kelly SJ. Biocompatibility of silver-modified polyester for antimicrobial protection of prosthetic valves. J Heart Valve Dis. 1997;6(5):553–61.PubMedGoogle Scholar
  26. 26.
    Wan AT, Conyers RAJ, Coombs CJ, Masterton JP. Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clin Chem. 1991;37(10):1683–7.PubMedGoogle Scholar
  27. 27.
    Donati F, Di Giacomo G, D’Adamio S, Ziranu A, Careri S, Rosa M, Maccauro G. Silver-coated hip megaprosthesis in oncological limb savage surgery. Biomed Res Int. 2016;2016:9079041.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Piccioli A, Donati F, Di Giacomo G, A Ziranu, Careri S, Spinelli MS, Giannini S, Giannicola G, Perisano C, Maccauro G. Infective complications in tumour endoprostheses implanted after pathological fracture of the limbs Injury 2016.  https://doi.org/10.1016/j.injury.2016.07.054. Available online 25 Aug 2016.
  29. 29.
    Donati F, Di Giacomo G, Ziranu A, Spinelli S, Perisano C, Rosa MA, Maccauro G. Silver coated prosthesis in oncological limb salvage surgery reduce the infection rate. J Biol Regul Homeost Agents. 2015;29(4 Suppl):149–55.PubMedGoogle Scholar
  30. 30.
    Bourne RB. Prophylactic use of antibiotic bone cement: an emerging standard—in the affirmative. J Arthroplast. 2004;19(suppl 1):69–72.CrossRefGoogle Scholar
  31. 31.
    Engesaeter LB, Lie SA, Espehaug B, et al. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0 to 14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand. 2003;74:644–51.CrossRefPubMedGoogle Scholar
  32. 32.
    Espehaug B, Engesaeter LB, Vollset SE, et al. Antibiotic prophylaxis in total hip arthroplasty: review of 10,905 primary cemented total hip replacements reported to the Norwegian Arthroplasty Register, 1987 to 1995. J Bone Joint Surg Br. 1997;79:590–5.CrossRefPubMedGoogle Scholar
  33. 33.
    Jiranek WA, Hanssen AD, Greenwald AS. Antibioticloaded bone cement for infection prophylaxis in total joint replacement. J Bone Joint Surg Am. 2006;88(11):2487–500.CrossRefPubMedGoogle Scholar
  34. 34.
    Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med. 2004;351:1645–54.CrossRefPubMedGoogle Scholar
  35. 35.
    Westrich GH, Salvati EA, Brause B. Postoperative infection. In: Bono JV, JC MC, Thornhill TS, Bierbaum BE, Turner RH, editors. Revision total hip arthroplasty. New York: Springer; 1999. p. 371–90.CrossRefGoogle Scholar
  36. 36.
    Raut VV, Siney PD, Wroblewski BM. One-stage revision of infected total hip replacements with discharging sinuses. J Bone Joint Surg Br. 1994;76:721–4.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Giulio Di Giacomo
    • 1
  • Fabrizio Donati
    • 2
  • Carlo Perisano
    • 1
  • Michele Attilio Rosa
    • 3
  • Giulio Maccauro
    • 1
  1. 1.Division of Orthopedic and TraumatologyCatholic University of the Sacred HeartRomeItaly
  2. 2.Division of OrthopedicBambino Gesù Children HospitalRomeItaly
  3. 3.Division of Orthopedic and TraumatologyMessina UniversityMessinaItaly

Personalised recommendations